関連する実験動画
Updated: Sep 10, 2025

14:49
Conducting Respiratory Oscillometry in an Outpatient Setting
Published on: April 8, 2022
7.4K
重度の耐火性喘息におけるオシロメトリーおよびスピロメトリーによる比率に対するドゥピルマブの影響
Robert Greig1, Philipp Suter1, Rory Chan1
1Scottish Centre for Respiratory Research, University of Dundee, Scotland.
Respiratory medicine
|August 22, 2025
まとめ
ドピルマブで治療された喘息患者の小さな呼吸道を評価するより簡単な方法をオシロメトリーで得られた比率は提供します. これらの比率は,スピロメトリーとともに,治療反応の評価に役立つ,顕著な改善を示した.
科学分野:
- 肺科
- 呼吸器医学
- 薬理学について
背景:
- インパルスオシロメトリー (IOS) は,喘息における小呼吸道機能不全を評価するための労力依存の方法である.
- 絶対IOS値の解釈は困難であり,分析を簡素化するためにオシロメトリーによる比率が提案された.
- 以前の研究では,IOSデータを解釈する際の比率の有用性を示唆していた.
研究 の 目的:
- 喘息患者のドピルマブ治療に対する反応の評価におけるオシロメトリーによる比率の有効性を評価する.
- オシロメトリーによる比率の変化とスピロメトリーによる比率と臨床結果を比較する.
主な方法:
- 異常なR5- R20/ R5比を有する患者は,治療への反応を特定し,分析した.
- オシロメトリーによる比率 (R5-R20/R5,X5/AX) とスピロメトリーによる比率 (FEV1/FVC,FEF25-75/FVC) を測定した.
- 2型バイオマーカー (エオシノフィル,FeNO) と喘息コントロールスコアも評価された.
主要な成果:
- ドピルマブ治療後のオシロメトリーによる比率 (R5- R20/ R5,X5/ AX) とスピロメトリーによる比率 (FEV1/ FVC,FEF25- 75/ FVC) の両方で有意な改善が見られた.
- 2型バイオマーカーと喘息のコントロールスコアも著しく改善しました.
- 標準化された応答は,治療応答を検出するオシロメトリー比率に対する良好な感度を示します.
結論:
- ドピルマブで治療された喘息患者の小呼吸道機能の有意な改善が示されています.
- これらの比率は,臨床環境における生物学的治療の反応を評価するために,絶対的なIOS値のより解釈可能な代替として機能する.
- オシロメトリー比率のさらなる検証は,現実の臨床実務において正当化される.
関連する概念動画
COPD: Management Using Bronchodilators and Corticosteroids
307
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
307
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Drugs Used in Lower Respiratory Disorders: Overview
578
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
578
Inhaled Medications
388
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
388
Asthma-III: Symptoms and Complications
2.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.6K

